Overview

Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma

Status:
NOT_YET_RECRUITING
Trial end date:
2028-01-01
Target enrollment:
Participant gender:
Summary
This is a pilot prospective longitudinal monocentric, non-comparative, nonrandomised, and non-controlled open study. is to test whether the intensity of 82-Rb uptake on PET acquisitions is associated to the aggressiveness of RCC on histology (ISUP grades), i.e., to successfully identify high-grade (ISUP grades 3 and 4) vs. lowgrade (ISUP grades 1 and 2) RCC.
Phase:
PHASE2
Details
Lead Sponsor:
Assistance Publique - Hpitaux de Paris
Collaborator:
Naogen Pharma
Treatments:
Rubidium-82